The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models

Pharmacology Biochemistry and Behavior

Volumn 116, Issue , 2014, Pages 107-115

  Moore, Catherine F ^a   Protzuk, Omar A ^a   Johnson, Bankole A ^a   Lynch, Wendy J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alcohol preferring (P) rats; Combination treatment; Ethanol; Naltrexone; Reinforcement; Topiramate

Indexed keywords

ALCOHOL; NALTREXONE; TOPIRAMATE; DRUG COMBINATION; FRUCTOSE;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL HOUSING; ARTICLE; CAGE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FOOD INTAKE; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REINFORCEMENT; RISK REDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL MODEL; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG COMBINATION; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ALCOHOL DRINKING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ETHANOL; FRUCTOSE; MODELS, ANIMAL; NALTREXONE; RATS; RATS, WISTAR;

EID: 84889566303     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.11.013     Document Type: Article

References (66)

1. N. Ait-Daoud, B.A. Johnson, T.J. Prihoda, and I.D. Hargita Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence Psychopharmacology (Berl) 154 2001 23 27 (Pubitemid 32186511)
2. R.F. Anton, S.S. O'Malley, D.A. Ciraulo, R.A. Cisler, D. Couper, and D.M. Donovan Combined pharmacotherapies and behavioral interventions for alcohol dependence JAMA 295 2006 2003 2017
3. R.L. Bell, Z.A. Rodd, L. Lumeng, J.M. Murphy, and W.J. McBride The alcohol-preferring P rat and animal models of excessive alcohol drinking Addiction Biol 11 2006 270 288 (Pubitemid 46696904)
4. K.R. Bertges, L.C. Bertges, J.O.T. de Souza, J.C. Machado, and C.A. Mourao-Junior Effects of acute topiramate dosing on open field behavior in mice Rev Neurocienc 19 2011 34 38
5. P. Bienkowski, W. Kostowski, and E. Koros Ethanol-reinforced behaviour in the rat: effects of naltrexone Eur J Pharmacol 374 1999 321 327 (Pubitemid 29313444)
6. G.A. Bray, P. Hollander, S. Klein, R. Kushner, B. Levy, and M. Fitchet A 6â€month randomized, placeboâ€controlled, doseâ€ranging trial of topiramate for weight loss in obesity Obes Res 11 2003 722 773
7. F.J. Breslin, B.A. Johnson, and W.J. Lynch Effect of topiramate treatment on ethanol consumption in rats Psychopharmacology (Berl) 207 2010 529 534
8. G. Chastain Alcohol, neurotransmitter systems, and behavior J Gen Psychol 133 2006 329 335 (Pubitemid 44825391)
9. J.A. Chester, and C.L. Cunningham GABAA receptor modulation of the rewarding and aversive effects of ethanol Alcohol 26 2002 131 143 (Pubitemid 34626307)
10. J. Chick, R. Anton, K. Checinski, R. Croop, D.C. Drummond, and R. Farmer A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse Alcohol Alcohol 35 2000 587 593
11. P. Clapp, S.V. Bhave, and P.L. Hoffman How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective Alcohol Res Health 31 2008 310 339
12. M. Darstein, C. Albrecht, L. Lopez-Francos, R. Knörle, S.M. Hölter, and R. Spanagel Release and accumulation of neurotransmitters in the rat brain - acute effects of ethanol in vitro and effects of long-term voluntary ethanol intake Alcohol Clin Exp Res 22 1998 704 709 (Pubitemid 28242478)
13. P.R. Dodd, A.M. Beckmann, M.S. Davidson, and P.A. Wilce Glutamate-mediated transmission, alcohol, and alcoholism Neurochem Int 37 2000 509 533 (Pubitemid 30386988)
14. M. Eravci, O. Schulz, T. Grospietsch, G. Pinna, O. Brödel, and H. Meinhold Gene expression of receptors and enzymes involved in GABAergic and glutamatergic neurotransmission in the CNS of rats behaviourally dependent on ethanol Br J Pharmacol 131 2000 423 432
15. T. Escher, and G. Mittleman Preclinical study: schedule†induced alcohol drinking: nonâ€selective effects of acamprosate and naltrexone Addiction Biol 11 2006 55 63 (Pubitemid 46696738)
16. J.C. Froehlich, J. Harts, L. Lumeng, and T.K. Li Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference Pharmacol Biochem Behav 35 1990 385 390 (Pubitemid 20075583)
17. K.I. Gabriel, and C.L. Cunningham Effect of topiramate on ethanol and saccharin consumption and preferences in C57BL â 6 J mice Alcohol Clin Exp Res 29 2005 75 80 (Pubitemid 40129214)
18. J.C. Garbutt Efficacy and tolerability of naltrexone in the management of alcohol dependence Curr Pharm Des 16 2010 2091 2097
19. N.W. Gilpin, and G.F. Koob Overview: neurobiology of alcohol dependence with a focus on motivational mechanisms Alcohol Res Health 31 2008 185 195
20. R.A. Gonzales, and F. Weiss Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens J Neurosci 18 1998 10663 10671 (Pubitemid 29016583)
21. F.L. Goodwin, M. Campisi, I. Babinska, and Z. Amit Effects of naltrexone on the intake of ethanol and flavored solutions in rats Alcohol 25 2001 9 19 (Pubitemid 32982858)
22. F.L. Greenway, K. Fujioka, R.A. Plodkowski, S. Mudaliar, M. Guttadauria, and J. Erickson Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial The Lancet 376 2010 595 605
23. A receptors in the acute and chronic effects of ethanol Psychopharmacology (Berl) 139 1998 2 19 (Pubitemid 28416878)
24. G.A. Hargreaves, and I.S. McGregor Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats Alcohol Clin Exp Res 31 2007 1900 1907 (Pubitemid 47609640)
25. D.S. Hasin, F.S. Stinson, E. Ogburn, and B.F. Grant Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions Arch Gen Psychiatr 64 2007 830
26. M. Heilig, and M. Egli Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms Pharmacol Therapeut 111 2006 855 876 (Pubitemid 44118437)
27. A. Heinz, A. Beck, J. Wrase, J. Mohr, K. Obermayer, and J. Gallinat Neurotransmitter systems in alcohol dependence Pharmacopsychiatry 42 2009 S95 S101
28. A. Heinz, A. Beck, S.M. Grüsser, A.A. Grace, and J. Wrase Identifying the neural circuitry of alcohol craving and relapse vulnerability Addict Biol 14 2009 108 118
29. C.J. Heyser, K. Moc, and G.F. Koob Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats Neuropsychopharmacology 28 2003 1463 1471 (Pubitemid 41070881)
30. P.L. Hoffman, L. Morrow, T.J. Phillips, and G.R. Siggins Neuroadaptation to ethanol at the molecular and cellular levels A. Noronha, M. Eckardt, K. Warren, Review of NIAAA's neuroscience and behavioral research portfolio NIAAA research monograph No. 34. NIH publication no. 00-457 2000 85 188
31. S.M. Hölter, M.S. Henniger, A.W. Lipkowski, and R. Spanagel Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats Psychopharmacology (Berl) 153 2000 93 102 (Pubitemid 32127907)
32. S.I. Johannessen Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs Epilepsia 38 1997 S18 S23
33. B.A. Johnson Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study Alcohol Clin Exp Res 28 2004 1137 1144 (Pubitemid 39108611)
34. B.A. Johnson Recent advances in the development of treatments for alcohol and cocaine dependence CNS drugs 19 2005 873 896
35. B.A. Johnson, N. Ait-Daoud, C.L. Bowden, C.C. DiClemente, J.D. Roache, and K. Lawson Oral topiramate for treatment of alcohol dependence: a randomised controlled trial The Lancet 361 2003 1677 1685 (Pubitemid 36577440)
36. B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, and K. Beyers Topiramate for treating alcohol dependence JAMA 298 2007 1641 1651
37. F. Kiefer, H. Jahn, T. Tarnaske, H. Helwig, P. Briken, and R. Holzbach Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study Arch Gen Psychiatry 60 2003 92 99 (Pubitemid 36070869)
38. S.G. Kim, B.D. Han, J.M. Park, M.J. Kim, and M.F. Stromberg Effect of the combination of naltrexone and acamprosate on alcohol intake in mice Psychiatry Clin Neurosci 58 2004 30 36 (Pubitemid 38200368)
39. A.C. King, J.R. Volpicelli, A. Frazer, and C.P. O'Brien Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence Psychopharmacology (Berl) 129 1 1997 15 22 (Pubitemid 27037445)
40. C.M. Knapp, M. Mercado, T.L. Markley, S. Crosby, D.A. Ciraulo, and C. Kornetsky Zonisamide decreases ethanol intake in rats and mice Pharmacol Biochem Behav 87 2007 65 72 (Pubitemid 46855820)
41. G.F. Koob Alcoholism: allostasis and beyond Alcohol Clin Exp Res 27 2003 232 243 (Pubitemid 36236646)
42. G.F. Koob, and M. Le Moal Drug abuse: hedonic homeostatic dysregulation Science 278 5335 1997 52 58 (Pubitemid 27446270)
43. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2009 217 238
44. G.F. Koob, A.J. Roberts, G. Schulteis, L.H. Parsons, C.J. Heyser, and P. Hyytiä Neurocircuitry targets in ethanol reward and dependence Alcohol Clin Exp Res 22 1998 3 9 (Pubitemid 28139190)
45. A. Kuzmin, T. Stenback, and S. Liljequist Memantine enhances the inhibitory effects of naltrexone on ethanol consumption Eur J Pharmacol 584 2008 352 356
46. A.D. Le, and E.M. Sellers Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake Alcohol Alcohol Suppl 2 1994 545 549
47. W.J. Lynch, C. Bond, F.J. Breslin, and B.A. Johnson Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse Psychopharmacology (Berl) 217 2011 3 12
48. W.J. Lynch, R.W. Morgan, C. Bond, M.D. Lycas, S. McIntosh, and B.A. Johnson The efficacy of topiramate at reducing ethanol's reinforcing effects is correlated with ethanol-induced extracellular glutamate concentrations in the nucleus accumbens of alcohol preferring rats College on problems of drug dependence meeting abstracts 2013
49. L.D. Middaugh, and A.L.E. Bandy Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice Psychopharmacology (Berl) 151 2000 321 327
50. L.D. Middaugh, A.M. Lee, and A.L.E. Bandy Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone Alcohol Clin Exp Res 24 2000 1172 1179 (Pubitemid 30650935)
51. R. Miranda Jr., J. MacKillop, P.M. Monti, D.J. Rohsenow, J. Tidey, and C. Gwaltney Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study Alcohol Clin Exp Res 32 2008 489 497 (Pubitemid 351300992)
52. A.L. Misra, R. Bloch, J. Vardy, S.J. Mule, and K. Verebely Disposition of (15, 16-3H) naltrexone in the central nervous system of the rat Drug Metab Dispos 4 1976 276 280
53. H. Myrick, R.F. Anton, X. Li, S. Henderson, P.K. Randall, and K. Voronin Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people Arch Gen Psychiatry 65 2008 466 475 (Pubitemid 351519896)
54. F. Navarrete, G. Rubio, and J. Manzanares Effects of naltrexone plus topiramate on ethanol selfâ€administration and tyrosine hydroxylase gene expression changes Addict Biol 2013 [Epub ahead of print]
55. S.S. O'Malley, S. Krishnan-Sarin, C. Farren, R. Sinha, and M. Kreek Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis Psychopharmacology (Berl) 160 2002 19 29 (Pubitemid 34169822)
56. J. Ortiz, L.W. Fitzgerald, M. Charlton, S. Lane, L. Trevisan, and X. Guitart Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system Synapse 21 4 1995 289 298 (Pubitemid 26039645)
57. S. Rösner, A. Hackl-Herrwerth, S. Leucht, P. Lehert, S. Vecchi, and M. Soyka Acamprosate for alcohol dependence Cochrane Database Syst Rev 9 2010
58. H.H. Samson, and T.F. Doyle Oral ethanol self-administration in the rat: effect of naloxone Pharmacol Biochem Behav 22 1985 91 99 (Pubitemid 15161531)
59. D.W.L. Self, and E.J. Nestler Molecular mechanisms of drug reinforcement and addiction Annu Rev Neurosci 18 1996 463 495
60. R.P. Shank, J.F. Gardocki, A.J. Streeter, and B.E. Maryanoff An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action Epilepsia 41s 2000 3 9
61. M.F. Stromberg, M. Casale, L. Volpicelli, J.R. Volpicelli, and C.P. O'Brien A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and β-funaltrexamine on ethanol consumption in the rat Alcohol 15 1998 281 289 (Pubitemid 28205097)
62. M.F. Stromberg, S.A. Mackler, J.R. Volpicelli, and C.P. O'Brien Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption Alcohol 23 2001 109 116 (Pubitemid 32377750)
63. Substance Abuse and Mental Health Services Administration (SAMHSA) Incorporating alcohol pharmacotherapies into medical practice Treatment improvement protocol (TIP) series 49. HHS publication no. (SMA) 2009 12 4380
64. E.M. Unterwald Naltrexone in the treatment of alcohol dependence J Addict Med 2 2008 121 127
65. J.R. Volpicelli, L.A. Volpicelli, and C.P. O'Brien Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment Alcohol Alcohol 30 1995 789 798 (Pubitemid 26017480)
66. N.A. Wages, L. Liu, J. O'Quigley, and B.A. Johnson Obtaining the optimal dose in alcohol dependence studies Front Psychiatry 3 2012 100 10.3389/fpsyt.2012.00100